Serum‑free‑medium‑type mesenchymal stem cell culture supernatant exerts a protective effect on A549 lung epithelial cells in acute lung injury induced by H2O2

Retraction in: /10.3892/or.2019.7087

  • Authors:
    • Jian Wu
    • An‑Quan Shang
    • Chu Chen
    • Wei‑Wei Wang
    • Cun‑Quan Xiong
    • Nai‑Zhou Guo
  • View Affiliations

  • Published online on: August 17, 2018     https://doi.org/10.3892/or.2018.6656
  • Pages: 3033-3039
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the mechanisms and protective effect of serum‑free‑medium‑type fetal placental mesenchymal stem cell (fPMSC) culture supernatant on A549 lung epithelial cells following treatment with hydrogen peroxide (H2O2). A549 lung epithelial cells were stimulated with different concentrations of H2O2, and the survival rate of the cells was examined by Cell Counting Kit‑8 (CCK‑8) assay. It was concluded that the H2O2 concentration when the cell survival rate was at 50% was the optimum condition to create an oxidative damage model. Hoechst 33258 staining and western blot analysis was used to validate the A549 lung epithelial cell model. Serum‑free medium was used to culture fPMSCs, and A549 lung epithelial cells treated with H2O2 were cultured with passage 3 MSC supernatant for 24 h. This was termed the supernatant group. Simultaneously, a damage group that was stimulated with H2O2 only, and a vitamin C (VC) group that was treated with H2O2 followed by 100 µmol/l VC in culture medium was also established. The apoptosis of the three groups was detected by flow cytometry, and western blotting was used to detect apoptosis‑associated and nuclear factor erythroid 2‑like 2 (Nrf2)‑kelch‑like ECH‑associated protein 1 (Keap1)‑antioxidant response element/oxidative stress‑associated protein expression. Following the CCK‑8 test, 600 µmol/l H2O2 was selected to stimulate the A549 lung epithelial cells for 24 h, which resulted in a A549 cell survival rate of 56.41±3.31%. Hoechst 33258 staining and western blotting also confirmed the reliability of the model. Flow cytometry demonstrated that the apoptotic rate of the cells in the VC and supernatant groups was reduced compared with that in the injury group. The difference between the supernatant group and the injury group was statistically significant. The detection of apoptosis‑associated proteins by western blotting revealed that the expression of apoptosis regulator BAX and Caspase‑3 in the VC and supernatant groups was decreased. Furthermore, the expression of B‑cell lymphoma‑2 was increased compared with that in the injury group, and the difference was statistically significant (P<0.05). Compared with that in the injury group, the expression of Nrf2 increased in the VC and supernatant groups, whereas the expression of Keap1 was decreased, and the difference was statistically significant (P<0.05). In conclusion, fPMSC supernatant exhibited an antioxidant capacity in A549 lung epithelial cells treated with H2O2 as a model of acute lung injury. The supernatant was found to reduce oxidative damage and inhibit apoptosis.

Introduction

Acute lung injury (ALI) is characterized by rapid onset lung and capillary endothelial cell damage caused by a series of factors (1), which may consequently result in pulmonary edema and hypoxic respiratory insufficiency. The clinical manifestations include progressive hypoxemia and respiratory distress. Severe ALI is termed acute respiratory distress syndrome (ARDS).

According to the literature (2), the mortality rate of ALI is 35–40%. Studies investigating the mechanism of ALI have revealed that its etiology involves imbalances between inflammatory and anti-inflammatory factors, as well as oxidant and antioxidant capacity (35), indicating that oxidative stress and excessive inflammatory factor release are critical factors that should be targeted in the treatment of lung injury.

When the body is confronted by a series of external stimuli, the oxidant and antioxidant system become imbalanced, which may lead to reactive oxygen species (ROS) accumulation, resulting in oxidative damage to tissues and organs. This phenomenon is termed oxidative stress (6). It has been demonstrated that the nuclear factor erythroid 2-like 2 (Nrf2)-kelch-like ECH-associated protein 1 (Keap1)-antioxidant response element (ARE) signaling pathway is a major regulator of the antioxidant response (7).

Under normal physiological conditions, Nrf2 molecules bind to the Keap1 protein molecules in the cytoplasm and are in an inactive state, and are therefore unable to translocate to the nucleus to activate transcription. When oxidative stress occurs, Nrf2 and Keap1 uncouple, Nrf2 is phosphorylated and translocates to the nucleus to bind ARE, and the transcription of downstream detoxification enzymes and antioxidant genes is initiated, in order to increase the antioxidant ability of the cell (8).

Mesenchymal stem cells (MSCs) originate from the early developmental mesoderm and are multipotent cells; they have been recognized as an ideal seed for tissue repair due to their strong multilineage differentiation potential and immunoregulatory ability (9). Shalaby et al (10) confirmed that MSCs alleviate lung injury and improve the activity of antioxidant enzymes in serum, by injecting MSCs into the caudal vein of a rat model. In addition, the use of MSCs in the treatment of lung disease is not limited to laboratory and animal models, but has also been partially developed as a clinical treatment. Wilson et al (11) used MSCs for the clinical treatment of ARDS, and achieved successful results. Furthermore, it has been suggested that MSCs have anti-inflammatory and antioxidant effects, due to their powerful paracrine function (12). When exogenous MSCs are administered, inflammation and oxidative stimuli are reduced through the secretion of anti-inflammatory factors and antioxidant enzymes, resulting in tissue injury prevention. Therefore, it has been suggested that the supernatant of MSCs also has the ability to repair tissue (13). Our previous study confirmed that serum-free-medium-type MSC supernatant has the ability to scavenge reactive oxygen species, and its total antioxidant capacity is equivalent to 100 µmol/l vitamin C (VC) (14). Therefore, 100 µmol/l was selected as a positive control in the present study, in order to elucidate whether the supernatant of MSC culture protected and/or repaired lung epithelial cells damaged by ROS.

Materials and methods

Establishment of an oxidative damage model

A549 cells, which were maintained in F12K medium at 37°C in 5% CO2, were purchased from the Chinese Academy of Sciences Cell Bank (Shanghai, China), and were cultured in high-glucose Dulbecco's modified Eagle's medium. When the cell confluence reached 80%, TrypLE reagents (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) were used to dissociate the cells in order to obtain a cell suspension. Cells were plated at a density of 5×103 cells/well in a 96-well plate, and subsequently cultured for 12 h at 37°C in an incubator.

Next, solutions with final concentrations of 200, 400, 500, 600 and 800 µmol/l hydrogen peroxide (H2O2) oxidation medium were prepared and added to the wells for 6, 12 or 24 h. CCK-8 was used to detect the survival rate of the cells. Each test was repeated five times in parallel. The optimal H2O2 concentration and stimulation duration for the oxidative damage model were those recorded at a cell survival rate of 50%, and this concentration was used for future experiments.

Hoechst 33258 staining

The A549 cell suspension was added into 6-well plates. The experiment used two groups: The normal group (untreated cells) and the H2O2-induced injury group. The two groups of cells were made into separate cell slides and stained with Hoechst 33258 for 5 min at 37°C. Cell damage in the two groups was observed under a fluorescence microscope.

Western blot analysis

Total protein concentration was determined using a bicinchoninic acid protein assay kit (cat. no. C503021; Sangon Biotech Co., Ltd., Shanghai, China) according to the manufacturer's protocols. Protein lysates from cells were prepared by using a radioimmunoprecipitation assay (RIPA) kit (Beyotime Institute of Biotechnology, Shanghai, China) according to the manufacturer's protocols. Equivalent amounts of protein (80 µg per lane) were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and subsequently transferred to polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). The membranes were blocked in 5% non-fat milk at room temperature for 1 h, and then incubated with BAX (cat. no. sc-7480; 1:1,000 dilution; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), Bcl-2 (cat. no. sc-7382; 1:1,000 dilution; Santa Cruz Biotechnology, Inc.), Caspase-3 (cat. no. 9661; 1:1,000 dilution; Cell Signaling Technology, Inc., Danvers, MA, USA), Nrf2 (cat. no. ab31163; 1:5,000 dilution; Abcam, Cambridge, MA, USA), Keap1 (cat. no. 10503-2-AP; 1:2,000 dilution; Proteintech Group, Inc., Chicago, IL, USA) and β-actin (cat. no. 3700S; 1:1,000 dilution; Cell Signaling Technology, Inc.) primary antibodies at 4°C overnight. Subsequent to being washed three times with Tris-buffered saline with Tween-20 (TBST), the membranes were probed with secondary peroxidase-conjugated antibodies (cat. nos. bs-0296R and bs-0295M; 1:1,000 dilution; Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China) at room temperature for 2 h. Subsequent to washing the membranes three times with TBST, the binding protein was developed and fixed in the darkroom following enhanced chemiluminescence (cat. no. C510043; Sangon Biotech Co., Ltd.). Western blot analysis was performed to determine the relative expression of the target protein normalized to β-actin.

Apoptosis detection by flow cytometry

Three experimental groups were set up for flow cytometry: i) H2O2 stimulation only (injury group); ii) H2O2 stimulation followed by 100 mol/l VC treatment for 24 h (VC group); and iii) H2O2 stimulation followed by passage 3 generation fetal placental mesenchymal stem cell (fPMSC) treatment for 24 h (supernatant group). In this experiment, stem cells were derived from human placentas that were extracted from healthy parturients by cesarean section. Informed consent was obtained from the pregnant women and their families, and the experiments were approved by the Ethics Committee of the General Hospital of Ningxia Medical University (Yinchuan, Ningxia, China). FPMSCs were extracted and then preserved in liquid nitrogen. After the three groups were cultured, apoptosis was detected by Annexin V-fluorescein isothiocyanate/propidium iodide (FITC/PI) (Yantai Shuangshuang Chemical Co., Ltd., Shandong, Jinan, China) double staining, and the differences in apoptosis between the groups were detected by flow cytometry (BD Accuri C6, version 1.0.264.21; Accuri Cytometers, Inc., Ann Arbor, MI, USA).

Detection of apoptosis-associated protein and antioxidant signaling pathway-associated protein expression by western blot analysis

Protein was extracted by RIPA kit following the culture of the three groups, and the expression of the apoptosis-associated proteins BAX (cat. no. sc-7480; Santa Cruz Biotechnology, Inc.), Bcl-2 (cat. no. sc-7382; Santa Cruz Biotechnology, Inc.), Caspase-3 (cat. no. 9661; Cell Signaling Technology, Inc.), Nrf2 (cat. no. ab31163; Abcam) and Keap1 (cat. no. 10503-2-AP; Proteintech Group, Inc.) were detected by western blot analysis as aforementioned.

Statistical analysis

SPSS 22.0 statistical software (IBM, Corp., Armonk, NY, USA) was used for the statistical analysis. The experimental data are expressed as the mean ± standard deviation. The results of different experiments were analyzed by single factor analysis of variance. Comparisons between groups were analyzed by the Student-Newman-Keuls test. P<0.05 was considered to indicate a statistically significant difference.

Results

Establishment of the oxidative damage model

H2O2 is a ROS that potently causes damage to the cell membrane. H2O2 may result in DNA damage, alterations in gene expression, and protein and lipid damage. However, this will not result in cell death and has the potential to be repaired if treated with a suitable protective agent (15). Therefore, H2O2 has been widely used in experimental models of oxidative stress. As different cell lines have varying tolerance to H2O2, it was important to establish a specific oxidative damage model for lung epithelial cells.

In the present study, it was demonstrated that the cell survival rate decreased as the concentration and duration of H2O2 treatment increased. When the concentration of H2O2 was 600 µmol/l and the duration of stimulation was 24 h, the survival rate of the cells was 56.41±3.31%. Therefore, this dose was used in subsequent experiments (Table I; Fig. 1).

Table I.

Effects of H2O2 at different concentrations and for different treatment lengths on A549 survival (mean ± standard deviation; n=5).

Table I.

Effects of H2O2 at different concentrations and for different treatment lengths on A549 survival (mean ± standard deviation; n=5).

H2O2 concentration, µmol/l

Treatment length200400500600800
6 h99.23±7.0793.94±5.4286.87±4.0472.75±5.9342.68±5.07
12 h96.59±1.5687.19±3.3074.98±5.6568.26±2.2631.68±6.57
24 h95.09±5.8675.74±5.3168.71±4.1956.41±3.3121.39±6.52

[i] H2O2, hydrogen peroxide.

Validity of the model were verified by Hoechst 33258 staining. Hoechst 33258 is a blue fluorescent dye that can penetrate the cell membrane. Under a fluorescence microscope, living cell nuclei show diffuse uniform light blue fluorescence, containing deep blue particles. When cells are undergoing apoptosis, nuclei appear a bright blue due to a high concentration of dye, and excess nuclei debris and dense particles are observed in the nucleus.

In the present study, the cells in the normal and injury groups were stained (Fig. 2), and the results demonstrated that the nuclei in the injury group exhibited different degrees of pyknosis, fragmentation and lysis (red arrow). Compared with the normal group, granular blue fluorescence (green arrow) was visible in the nucleus. Marked apoptosis was observed in the injury group.

Validity of the model, as verified by western blotting

BAX and Bcl-2 are important apoptosis regulating genes. Compared with the normal control group, the injury group exhibited significantly increased expression of the BAX gene, whereas the expression of Bcl-2 gene was significantly decreased (P<0.05; Fig. 3).

Flow cytometry

Annexin V-FITC/PI double staining results (Fig. 4) demonstrated that the cell apoptosis in the VC and supernatant groups was significantly lower compared with that in H2O2 injury group. However, only late apoptosis and overall apoptosis rates in the supernatant group were significantly different from those in the injury group (P<0.05).

Expression of apoptosis-associated proteins

The apoptosis-associated proteins BAX, Bcl-2 and Caspase-3 were detected by western blot analysis (Fig. 5). Compared with that in the injury group, the expression of the BAX and Caspase-3 genes in the supernatant group was decreased, whereas the expression of Bcl-2 was increased. These differences were statistically significant (P<0.05).

Expression of antioxidant signaling pathway-associated proteins

The expression of Nrf2-Keap1-ARE signaling pathway-related proteins in the three groups was detected by western blot analysis (Fig. 6). The results revealed that compared with the injury group, the VC and supernatant groups exhibited a decreased level of Keap1 expression, whereas the expression level of Nrf2 was increased. These differences were also statistically significant (P<0.05).

Discussion

ALI is one of the most common diseases of the respiratory system. Due to the occurrence of acute alveolar inflammatory edema accompanied by rapid onset and a poor prognosis, ALI can rapidly develop into ARDS (16). Furthermore, the morbidity and mortality rates remain high. Therefore, a reliable and effective method of treatment for the disease is urgently required. Recently, multiple studies have demonstrated that ALI is associated with oxidative stress, and research into oxidative stress has gained increasing interest (17).

Oxidative stress is a result of an imbalance of oxidant and antioxidant substances, due to excessive ROS production by the organism, which results in oxidative damage to the tissues and cells. The lungs in particular are an organ sensitive to oxidative stress (18,19). Therefore, preventing oxidative stress has become an important target for the treatment of lung diseases. The Nrf2-Keap1-ARE signaling pathway is recognized as a classic antioxidant pathway. Activation of the nuclear transcription factor Nrf2 promotes the expression of downstream molecular phase detoxification enzymes and antioxidant proteins, in order to improve antioxidant capacity (20). It has been demonstrated that Nrf2 activation may increase resistance to a series of diseases caused by oxidative stress, including central nervous system, cardiovascular, liver and kidney diseases, as well as tumors (21,22). Therefore, the present study hypothesized that the protective effects of MSCs against the oxidative damage of lung epithelial cells may also be through this signaling pathway.

MSCs, as an ideal seed for tissue repair, have been widely recognized for their strong immune regulation and antioxidant capacity. Several studies have indicated that MSCs may be used to treat a variety of diseases (23,24). In recent years, the use of MSCs has represented a breakthrough in the treatment of certain diseases, with promise shown for patients with refractory diseases in particular (25,26). However, clinical application of MSCs may be problematic due to their potential tumorigenicity (27,28). MSCs have low immunogenicity, but when in direct contact with the immune system, the risks and side effects should not be ignored, as a risk of tumor formation in MSCs has been previously reported in the literature (29,30).

The initial step in the present study was to use H2O2 to model oxidative stress, and the cell survival rate, morphology and the expression of apoptosis-associated proteins were detected to ensure that the oxidative damage model of lung epithelial cells was successfully established for subsequent experiments. The experimental results demonstrated that, when lung epithelial cells were stimulated by 600 µmol/l H2O2, the cell survival rate was 56.41%. Following Hoechst 33258 staining, marked apoptosis was observed in cells in the injury group. The integrity of the cytoplasm decreased, and nuclear fragmentation and nucleation occurred to different degrees. In addition, fluorescence staining in the nuclei was dense and compact. Western blot analysis demonstrated that compared with the normal group, the injury group exhibited increased expression of BAX, while Bcl-2 expression was decreased, and the difference was statistically significant (P<0.05). This confirmed that the model was successful.

Subsequently, the supernatant of fPMSCs was applied to lung epithelial cells following injury. Compared with the injury group, the supernatant group exhibited reduced cell apoptosis and apoptotic gene expression, and the expression of the antioxidant pathway key transcription factor Nrf2 increased. The antioxidant effects observed in the cells treated with fPMSC culture supernatant were higher compared with those in the 100 µmol/l VC treated group. This suggested that fPMSC supernatant protected the lung epithelial cells against oxidative stress induced by H2O2, and this may have been via activation of the Nrf2-Keap1-ARE signaling pathway.

The detection of apoptotic genes and proteins associated with the Nrf2-Keap1-ARE signaling pathway by western blot analysis provided results consistent with expectations, and the differences were statistically significant (P<0.05). The positive effect of fPMSCs supernatant on the oxidative damage of lung epithelial cells was confirmed. During the process of Annexin V FITC/PI double staining to detect apoptosis using flow cytometry, it was determined that compared with that in the injury group, the apoptotic rate in the VC and supernatant groups was decreased, but only late apoptosis and the overall apoptotic rate in the supernatant group were significantly different from that in the injury group (P<0.05).

It was hypothesized that the lung epithelial cells damaged by H2O2 may have possessed a different proliferative capacity at the later stage due to the different degrees of apoptosis. Once the three cell groups were cultured, the dominant cells proliferated in large numbers, while the apoptotic cells did not proliferate or died. Therefore, in the detection of apoptotic cells by flow cytometry, the number of living cells accounted for a larger ratio, while the rate of apoptotic cells decreased, which may explain why the western blot analysis detected significant differences between the groups at the molecular level, whereas at the cellular level, the flow cytometry results were not always significantly different. This suggests that appropriate optimization of the experimental conditions is required for the next phase of research.

In summary, fPMSC culture supernatant was demonstrated to exhibit antioxidant ability, and to a certain extent, to reduce the apoptosis induced by H2O2, at least in part via activation of the Nrf2-Keap1-ARE signaling pathway. This suggested that for the clinical application of MSCs, in addition to the cells themselves, the culture supernatant may also have potential therapeutic value. In addition to its antioxidative effects, the supernatant of MSCs may have other beneficial functions, which require further investigation.

Acknowledgements

The authors would like to express their sincere thanks to Spandidos Publications Ltd. for the English language revisions in this manuscript.

Funding

The present study was supported by the Youth Medical Talent of Jiangsu Province (grant no. QNRC2016475) and the Science and Technology Commission of Yancheng City (grant no. YK2015002).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

JW and AS contributed to study concept and design, acquisition of data, analysis and interpretation of data, and drafting of the manuscript; CC contributed to the statistical analysis; WW contributed to the study concept, study supervision and critical revision of the manuscript; CX and NG contributed to the study concept and design, study supervision and critical revision of the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

All procedures performed involving human participants were in accordance with the ethical standards of the Ethics Committee of the General Hospital of Ningxia Medical University (Yinchuan, Ningxia, China), and the First People's Hospital of Yancheng City (Yancheng, Jiangsu, China), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants enrolled in the study. From all participants, tissue samples were included in the sample pool and informed consent was collected from all participants prior to storage of the sample. An ethical review of the sample library has been submitted and the review contains the informed consent of all participants.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Jin Z, Suen Chun K and Ma D: Perioperative ‘remote’ acute lung injury: Recent update. J Biomed Res. 31:197–212. 2017.PubMed/NCBI

2 

Hayes M, Curley G, Ansari B and Laffey JG: Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Crit Care. 16:2052012. View Article : Google Scholar : PubMed/NCBI

3 

Han F, Luo Y, Li Y, Liu Z, Xu D, Jin F and Li Z: Seawater induces apoptosis in alveolar epithelial cells via the Fas/FasL-mediated pathway. Respir Physiol Neurobiol. 182:71–80. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Al-Biltagi MA, Abo-Elezz AA, Elshafiey RM, Suliman GA, Mabrouk MM and Mourad HA: The predictive value of soluble endothelial selectin plasma levels in children with acute lung injury. J Crit Care. 32:31–35. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Trajano Lima ET, Sternberg C, Caetano M, Silva Santos MA, Porto LC, Santos JC, Ribeiro ML, Magalhães CB, Zin WA, Benjamim CF, et al: Endotoxin-induced acute lung injury is dependent upon oxidative response. Inhal Toxicol. 23:918–926. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Poljsak B, Suput D and Milisav I: Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev. 2013:9567922013. View Article : Google Scholar : PubMed/NCBI

7 

Yang C, Jiang J, Yang X, Wang H and Du J: Stem/progenitor cells in endogenous repairing responses: New toolbox for the treatment of acute lung injury. J Transl Med. 14:472016. View Article : Google Scholar : PubMed/NCBI

8 

Miller DM, Singh IN, Wang JA and Hall ED: Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic Biol Med. 57:1–9. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Suniara RK, Jenkinson EJ and Owen JJ: An essential role for thymic mesenchyme in early T cell development. J Exp Med. 191:1051–1056. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Shalaby SM, El-Shal AS, Abd-Allah SH, Selim AO, Selim SA, Gouda ZA, El Motteleb Abd DM, Zanfaly HE, El-Assar HM and Abdelazim S: Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice. Cytotherapy. 16:764–775. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, et al: Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med. 3:24–32. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Castro-Manrreza ME and Montesinos JJ: Immunoregulation by mesenchymal stem cells: Biological aspects and clinical applications. J Immunol Res. 2015:3949172015. View Article : Google Scholar : PubMed/NCBI

13 

Zhang G, Zou X, Huang Y, Wang F, Miao S, Liu G, Chen M and Zhu Y: Mesenchymal stromal cell-derived extracellular vesicles protect against acute kidney injury through anti-oxidation by enhancing Nrf2/ARE activation in Rats. Kidney Blood Press Res. 41:119–128. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Pleyer L, Valent P and Greil R: Mesenchymal stem and progenitor cells in normal and dysplastic hematopoiesis-masters of survival and clonality? Int J Mol Sci. 17:10092016. View Article : Google Scholar :

15 

Lv H, Liu Q, Wen Z, Feng H, Deng X and Ci X: Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 12:311–324. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 141:460–470. 2000.

17 

Keum YS and Choi BY: Molecular and chemical regulation of the Keap1-Nrf2 signaling pathway. Molecules. 19:10074–10089. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Wang Z, Ji C, Wu L, Qiu J, Li Q, Shao Z and Chen G: Tert-butylhydroquinone alleviates early brain injury and cognitive dysfunction after experimental subarachnoid hemorrhage: Role of Keap1/Nrf2/ARE pathway. PLoS One. 9:e976852014. View Article : Google Scholar : PubMed/NCBI

19 

Liu X, Zheng P, Xiaodong G, Guanghui D, Hongbin CH, Zan ZH, Rongrong H, Xinxin N, Jing SH and Yihua A: A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cell Research & Therapy. 5:1–9. 2014. View Article : Google Scholar

20 

Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY, Park HJ, Park SY, Kim BR, Kim JW, et al: Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: A pilot study. Liver Int. 34:33–41. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, et al: Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy. JAMA. 308:2369–2379. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Ni S, Wang D, Qiu X, Pang L, Song Z and Guo K: Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling. Int J Clin Exp Pathol. 8:7752–7761. 2015.PubMed/NCBI

23 

Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI and Park WS: Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 164:966–972. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Haddad R and Saldanha-Araujo F: Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: What do we know so far? BioMed Res Int. 2014:2168062014. View Article : Google Scholar : PubMed/NCBI

25 

Martinet L, Fleury-Cappellesso S, Gadelorge M, Dietrich G, Bourin P, Fournié JJ and Poupot R: A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells. Eur J Immunol. 39:752–762. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Tasso R, Augello A, Carida' M, Postiglione F, Tibiletti MG, Bernasconi B, Astigiano S, Fais F, Truini M, Cancedda R, et al: Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis. 30:150–157. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Chen W, Huang Y, Han J, Yu L, Li Y, Lu Z, Li H, Liu Z, Shi C, Duan F, et al: Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunol Res. 64:831–840. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Sabin K and Kikyo N: Microvesicles as mediators of tissue regeneration. Transl Res. 163:286–295. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Sdrimas K and Kourembanas S: MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal. 21:1905–1915. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Hashemian SJ, Kouhnavard M and Nasli-Esfahani E: Mesenchymal stem cells: Rising concerns over their application in treatment of type one diabetes mellitus. J Diabetes Res. 2015:6751032015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

November-2018
Volume 40 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu J, Shang AQ, Chen C, Wang WW, Xiong CQ and Guo NZ: Serum‑free‑medium‑type mesenchymal stem cell culture supernatant exerts a protective effect on A549 lung epithelial cells in acute lung injury induced by H2O2 Retraction in /10.3892/or.2019.7087. Oncol Rep 40: 3033-3039, 2018
APA
Wu, J., Shang, A., Chen, C., Wang, W., Xiong, C., & Guo, N. (2018). Serum‑free‑medium‑type mesenchymal stem cell culture supernatant exerts a protective effect on A549 lung epithelial cells in acute lung injury induced by H2O2 Retraction in /10.3892/or.2019.7087. Oncology Reports, 40, 3033-3039. https://doi.org/10.3892/or.2018.6656
MLA
Wu, J., Shang, A., Chen, C., Wang, W., Xiong, C., Guo, N."Serum‑free‑medium‑type mesenchymal stem cell culture supernatant exerts a protective effect on A549 lung epithelial cells in acute lung injury induced by H2O2 Retraction in /10.3892/or.2019.7087". Oncology Reports 40.5 (2018): 3033-3039.
Chicago
Wu, J., Shang, A., Chen, C., Wang, W., Xiong, C., Guo, N."Serum‑free‑medium‑type mesenchymal stem cell culture supernatant exerts a protective effect on A549 lung epithelial cells in acute lung injury induced by H2O2 Retraction in /10.3892/or.2019.7087". Oncology Reports 40, no. 5 (2018): 3033-3039. https://doi.org/10.3892/or.2018.6656